Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Agilent Technologies Inc. filings document financial reporting and governance matters for an analytical and clinical laboratory technology company. Form 8-K reports include quarterly financial-result releases, Regulation FD disclosures, non-GAAP measure explanations, executive officer transitions, compensatory arrangements and amendments to charter and bylaws.
Proxy and annual-meeting filings cover director elections, stockholder voting, executive compensation, equity awards and the phased declassification of the board. The records also identify governance changes tied to the company’s Delaware certificate of incorporation and bylaws, together with furnished press releases and related exhibits.
Agilent Technologies, Inc. (A) reported a change in ownership by a senior vice president on a Form 4. On November 18, 2025, the officer received 5,368 shares of common stock through a grant of restricted stock units at a stated price of $0, reflecting an equity award rather than a market purchase. Following this grant, the reporting person beneficially owned 7,043 shares directly.
The restricted stock units were granted under the Agilent Technologies, Inc. 2018 Stock Plan and are scheduled to vest in four equal annual installments beginning on November 18, 2026, meaning the officer will gain full access to the shares over a four-year period if vesting conditions are met.
Agilent Technologies, Inc. reported insider equity holdings and stock options for a senior executive. A Senior Vice President beneficially owns 1,675 shares of Agilent common stock in direct form. The executive also holds an employee stock option to buy 4,891 shares of common stock at an exercise price of $116.98 per share, granted under the Agilent Technologies, Inc. 2018 Stock Plan in compliance with Rule 16b-3. The option has an expiration date of 03/31/2035 and is scheduled to vest in four equal annual installments, beginning on the first anniversary of the grant date, with 03/31/2026 stated as the first vesting date. All reported holdings are listed as directly owned.
Agilent Technologies (ticker: A) reported a stock-based award to its Senior Vice President and Chief Financial Officer. On 11/18/2025, the executive received 11,726 shares of common stock in the form of restricted stock units granted under the Agilent Technologies, Inc. 2018 Stock Plan. The award was reported at a price of $0, reflecting that this is an equity grant rather than an open-market purchase.
The restricted stock units will vest in four equal annual installments beginning on November 18, 2026, meaning the executive will receive portions of the shares over four years as long as the vesting conditions are met. This type of compensation is commonly used to align executive incentives with long-term company performance.
Agilent Technologies, Inc. (A) reported an initial statement of beneficial ownership for a Senior Vice President. The reporting officer is identified as an executive (Senior Vice President) and, according to the filing, holds 0 shares of Agilent common stock in direct ownership and reports no derivative securities such as options or warrants. The form is filed by one reporting person, with a power of attorney noted in the remarks.
Agilent Technologies, Inc. (A) reported an insider equity transaction by a Senior Vice President in a Form 4. On 11/14/2025, the executive surrendered 27 shares and 51 shares of common stock back to Agilent at a price of $146.82 per share. These shares were withheld to cover tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. After these routine tax-related transactions, the reporting person beneficially owned 5,769.0318 and then 5,718.0318 shares of Agilent common stock directly.
Agilent Technologies, Inc. reported an insider equity transaction by a senior executive. A Senior Vice President filed a Form 4 showing two tax-related share surrenders on 11/14/2025. The executive surrendered 44 shares and 56 shares of Agilent common stock to the company to cover tax liabilities arising from the vesting of restricted stock units, in transactions reported under Rule 16b-3.
After these transactions, the executive beneficially owned 19,163.9266 shares of Agilent common stock directly and 2,607.6856 shares indirectly through a spouse. The holdings include shares acquired under Agilent’s dividend reinvestment plan and its Employee Stock Purchase Plan, which were obtained in transactions exempt from Section 16 reporting rules.
Agilent Technologies (A) reported insider share transactions by its President and CEO related to equity compensation taxes. On 11/14/2025, the executive surrendered 203 shares of common stock to Agilent at a price of $146.82 per share to cover tax liabilities from vested restricted stock units, leaving 33,245 shares beneficially owned afterward. On the same date, the executive surrendered an additional 276 shares at $146.82 per share for the same tax purpose, resulting in 32,969 shares beneficially owned following these transactions. These are routine tax-withholding transactions under Rule 16b-3 rather than open-market purchases or sales.
Agilent Technologies, Inc. executive reports tax-related share surrender
An Agilent Technologies (A) Senior Vice President reported two small transactions in company common stock on 11/14/2025. The reporting person surrendered 37 shares and 58 shares of Agilent common stock to the company at a price of $146.82 per share to cover tax liabilities arising from the vesting of restricted stock units, in accordance with Rule 16b-3. After these transactions, the executive directly beneficially owns 8,064 shares of Agilent common stock.
Agilent Technologies (A) disclosed a Form 4 for an executive stock transaction involving VP and Corporate Controller Rodney Gonsalves. On 11/14/2025, Gonsalves surrendered 77 shares and 99 shares of Agilent common stock to the company to cover tax liabilities arising from the vesting of restricted stock units, with both transactions priced at $146.82 per share under Rule 16b-3. After these tax-withholding transactions, he beneficially owned 30,924.6872 shares directly. The filing notes that this direct amount includes 52.6440 shares acquired through Agilent’s dividend reinvestment plan and 76.3520 shares acquired via an employee stock purchase plan in transactions exempt from short-swing profit rules. In addition, 40.192 shares are held indirectly through the Gonsalves Trust, for which Rodney and Rochelle Gonsalves serve as trustees.
Agilent Technologies insider plans a small Rule 144 stock sale. The notice reports that Padraig Mcdonnell intends to sell 911 shares of Agilent common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of 130,491.64. The filing notes 283,500,427 common shares outstanding. The shares to be sold were acquired via restricted stock vesting from the issuer on 11/15/2024 and 11/16/2024, in amounts of 523 and 388 shares as compensation.
Over the past three months, the same seller disposed of 2,000 Agilent common shares on 09/02/2025 for gross proceeds of 249,760.00 and 12,490 shares on 11/12/2025 for gross proceeds of 1,873,500.00. The signer represents that they do not know of any material adverse information about Agilent’s current or prospective operations that has not been publicly disclosed.